Literature DB >> 25006687

Permeation enhancer strategies in transdermal drug delivery.

Harneet Marwah1, Tarun Garg1, Amit K Goyal1, Goutam Rath1.   

Abstract

Today, ∼74% of drugs are taken orally and are not found to be as effective as desired. To improve such characteristics, transdermal drug delivery was brought to existence. This delivery system is capable of transporting the drug or macromolecules painlessly through skin into the blood circulation at fixed rate. Topical administration of therapeutic agents offers many advantages over conventional oral and invasive techniques of drug delivery. Several important advantages of transdermal drug delivery are prevention from hepatic first pass metabolism, enhancement of therapeutic efficiency and maintenance of steady plasma level of the drug. Human skin surface, as a site of drug application for both local and systemic effects, is the most eligible candidate available. New controlled transdermal drug delivery systems (TDDS) technologies (electrically-based, structure-based and velocity-based) have been developed and commercialized for the transdermal delivery of troublesome drugs. This review article covers most of the new active transport technologies involved in enhancing the transdermal permeation via effective drug delivery system.

Entities:  

Keywords:  Iontophoresis; nano-carriers; permeation enhancement; sonophoresis; transdermal drug delivery

Mesh:

Substances:

Year:  2014        PMID: 25006687     DOI: 10.3109/10717544.2014.935532

Source DB:  PubMed          Journal:  Drug Deliv        ISSN: 1071-7544            Impact factor:   6.419


  56 in total

1.  Transcutaneous immunization with a nontypeable Haemophilus influenzae dual adhesin-directed immunogen induces durable and boostable immunity.

Authors:  Laura A Novotny; Lauren O Bakaletz
Journal:  Vaccine       Date:  2020-01-27       Impact factor: 3.641

2.  A Novel Eutectic-Based Transdermal Delivery System for Risperidone.

Authors:  Faisal Al-Akayleh; Samer Adwan; Mai Khanfar; Nasir Idkaidek; Mayyas Al-Remawi
Journal:  AAPS PharmSciTech       Date:  2020-11-22       Impact factor: 3.246

Review 3.  Recent advances in cyclosporine drug delivery: challenges and opportunities.

Authors:  Dhrumi Patel; Sarika Wairkar
Journal:  Drug Deliv Transl Res       Date:  2019-12       Impact factor: 4.617

Review 4.  Transfersomes: a Revolutionary Nanosystem for Efficient Transdermal Drug Delivery.

Authors:  Muhammad Waseem Akram; Humzah Jamshaid; Fiza Ur Rehman; Muhammad Zaeem; Jehan Zeb Khan; Ahmad Zeb
Journal:  AAPS PharmSciTech       Date:  2021-12-01       Impact factor: 3.246

Review 5.  Recent Advancement in Topical Nanocarriers for the Treatment of Psoriasis.

Authors:  Prativa Biswasroy; Deepak Pradhan; Biswakanth Kar; Goutam Ghosh; Goutam Rath
Journal:  AAPS PharmSciTech       Date:  2021-05-26       Impact factor: 3.246

6.  Modular Fabrication of Intelligent Material-Tissue Interfaces for Bioinspired and Biomimetic Devices.

Authors:  John R Clegg; Angela M Wagner; Su Ryon Shin; Shabir Hassan; Ali Khademhosseini; Nicholas A Peppas
Journal:  Prog Mater Sci       Date:  2019-07-17

Review 7.  Ethosomes as Nanocarriers for the Development of Skin Delivery Formulations.

Authors:  Ana Cláudia Paiva-Santos; Ana Luísa Silva; Catarina Guerra; Diana Peixoto; Miguel Pereira-Silva; Mahdi Zeinali; Filipa Mascarenhas-Melo; Ricardo Castro; Francisco Veiga
Journal:  Pharm Res       Date:  2021-05-25       Impact factor: 4.200

Review 8.  Influencing factors and drug application of iontophoresis in transdermal drug delivery: an overview of recent progress.

Authors:  Yu Wang; Lijuan Zeng; Wenting Song; Jianping Liu
Journal:  Drug Deliv Transl Res       Date:  2021-01-23       Impact factor: 4.617

Review 9.  New perspectives on the topical management of recurrent candidiasis.

Authors:  Ana Carolina S Ré; Jayanaraian F Martins; Marcílio Cunha-Filho; Guilherme M Gelfuso; Carolina P Aires; Taís Gratieri
Journal:  Drug Deliv Transl Res       Date:  2021-01-19       Impact factor: 4.617

10.  Transdermal administration of melatonin coupled to cryopass laser treatment as noninvasive therapy for prostate cancer.

Authors:  Laura Terraneo; Paola Bianciardi; Eleonora Virgili; Elena Finati; Michele Samaja; Rita Paroni
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.